1. Versteegh FGA, Schellekens JFP, Fleer A, Roord JJ. Pertussis: a concise historical review including diagnosis, incidence, clinical manifestations and the role of treatment and vaccination in
management. Rev Med Microbiol 2005;16:79–89;
2. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol
Rev 2005;18:326–382;
3. Principles and Practices of Pediatric Infectious Diseases. Long SS, Prober CG, Fischer M. Bordetella pertussis (Pertussis) and Other Bordetella Species. Philadelphia, PA, Fifth Edition, 2018
by Elsevier. pp: 4574-4618.)
4. Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005; 115:1422–1427;
5. Sönmez C, Çöplü N, Gözalan A, et al. Uzamış öksürüğü olan erişkinlerde Bordetella pertussis enfeksiyonunun serolojik olarak değerlendirilmesi [Serological evaluation of Bordetella pertussis
infection in adults with prolonged cough]. Mikrobiyol Bul. 2016;50(3):361-370. doi:10.5578/mb.27692
6. Schoch CL, Ciufo S, Domrachev M, et al. NCBI Taxonomy: a comprehensive update on curation, resources and tools. Database (Oxford). 2020;2020:baaa062. doi:10.1093/database/baaa062)
7. World Health Organization (WHO). The immunological basis for immunization series: module 4: pertussis, update 2017. ISBN 978-92-4-151317-3
8. Ulusal Mikrobiyoloji Standartları Bulaşıcı Hastalıklar Laboratuvar Tanı Rehberi 01.01.2015 / Sürüm: 1.1 / B-MT-01 / Mikrobiyolojik Tanımlama / Bakteriyoloji Boğmacanın mikrobiyolojik
tanısı.
9. World Health Organization (WHO). Laboratory manual for the diagnosis of whooping cough caused by Bordetella pertussis-Bordetella parapertussis. Update 2014 (7 January 2020 publica-
tion)
10. Belcher T, Dubois V, Rivera-Millot A, Locht C, Jacob-Dubuisson F. Pathogenicity and virulence of Bordetella pertussis and its adaptation to its strictly human host. Virulence. 2021;12(1):2608-
2632. doi:10.1080/21505594.2021.1980987
11. Zeynep Ceren Karahan. Bordetella türleri. In Wilke Topcu A, Soyletir G, Doğanay M. Enfeksiyon Hastalıkları ve Mikrobiyolojisi. 4. Baskı, Nobel Tıp Kitabevleri 2017: 1981-1985
12. Esen B, Cöplü N, Kurtoğlu D, Gözalan A, Akin L (2007) Prevalence of high antibody titers of pertussis in Turkey: reflection of circulating microorganism and a threat to infants. J Clin Lab
Anal 21:154–161
13. Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clinical Infectious Diseases 1999; 28 (Suppl. 2): S107–111).
14. Jackson DW, Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes . Epidemiol. Infect. (2014), 142, 672–684).
15. Sunarno S, Sofiah SN, Amalia N, Hartoyo Y, Rizki A, Puspandari N, et al. (2022) Laboratory and epidemiology data of pertussis cases and close contacts: A 5-year case-based surveillance of
pertussis in Indonesia, 2016–2020. PLoS ONE 17(4): e0266033;
16. World Health Organization, “Immunization, Vaccines And Biologicals. Vaccine preventable diseases Vaccines monitoring system 2020 Global Summary Reference Time Series: Pertussis.” pp.
1–24, 2020;
17. https://www.cdc.gov/pertussis/countries/index.html#print (Erişim tarihi: 24 Kasım 2023)
18. https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2018_pertussis.pdf (Erişim tarihi: 24 Kasım 2023)
19. Dilli D, Bostanci I, Dallar Y, Buzgan T, Irmak H, Torunoglu MA. Recent findings on pertussis epidemiology in Turkey. Eur J Clin Microbiol Infect Dis 2008;27:335-41).
20. Cöplü N, Esen B, Kurtoğlu D, Gözalan A, Miyamura K, Yoshida I. Laboratuvarimizda hazirlanan ELISA testinin boğmaca serolojisinde standardizasyonu ve seroepidemiyolojik bir calişmada
kullanilmasi [Standardization of an in-house ELISA for pertussis serology and its application in a seroepidemiological study]. Mikrobiyol Bul. 2005;39(3):281-289.
21. Türkoglu E, Sönmez C, Kurugöl Z, Çöplü N, Koturoğlu G. Pertussis serosurveillance study in Izmir, Turkey. J Trop Pediatr. 2015;61(1):32-36. doi:10.1093/tropej/fmu062
22. Türkoğlu E, Sönmez C, Özer E, Çöplü N, Kurugöl Z. Low pertussis antibody levels in maternal and umbilical cord blood samples in Turkey. Turk J Pediatr. 2016;58(6):573-578. doi:10.24953/
turkjped.2016.06.001
23. Vatansever U, Cöplü N, Oner N, et al. Seroprevalance of Bordetella pertussis antibodies among healthy adolescent girls in Edirne. Swiss Med Wkly. 2005;135(35-36):531-536. doi:10.4414/
smw.2005.11096
24. Duranoglu L, Sönmez C, Vurucu S, et al. Evaluation of pertussis immunity status in schoolchildren immunized with whole-cell vaccine. Epidemiol Infect. 2010;138(2):299-303. doi:10.1017/
S095026880999032X
25. Aksakal FN, Cöplü N, Ceyhan MN, Sönmez C, Ozkan S, Esen B, Ilhan MN, Aygün R. High incidence of pertussis among schoolchildren with prolonged cough in Turkey. Tohoku J Exp Med
2007;211:353–358
26. Gürsel D, Aslan A, Sönmez C, et al. Uzamış Öksürüğü Olan Çocuklarda Kültür, Gerçek Zamanlı Polimeraz Zincir Reaksiyonu ve Seroloji ile Bordetella pertussis Enfeksiyonunun Araştırılması[Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough]. Mikrobiyol Bul. 2012;46(2):211-224.
27. Coplü N, Nar S, Efsun A, Kurtoğlu D, Esen B. Kirikkale’nin bir köyünde doğrulanmiş bir boğmaca olgusu nedeniyle yapilan saha araştirmasi [A field survey carried out on the confirmation
of a pertussis case in a village of Kirikkale Province, Turkey]. Mikrobiyol Bul. 2007;41(2):175-183.
28. Marchal C, Belhassen M, Guiso N, et al. Cocooning strategy: Pertussis vaccination coverage rate of parents with a new-born in 2016 and 2017 in France. Front Pediatr. 2022;10:988674. Pub-
lished 2022 Oct 18. doi:10.3389/fped.2022.988674).
29. Heininger U, Cherry JD, Stehr K, et al. Comparative efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in
German children after household exposure. Pediatrics 1998;102:546—53).
30. Ebell MH, Marchello C, Callahan M. Clinical diagnosis of Bordetella pertussis infection: A systematic review. J Am Board Fam Med 2017; 3: 308–319;
31. Kilgore PE, Salim AM, Zervos MJ, Schmitt H. Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev Am Soc Microbiol 2016;3:449–486;
32. Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev 2008;3:201–212;
33. Tiwari T, Murphy TV, Moran J, Natioonal Immunizationb Program, CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Gui-
delines. MMWR Recomm Rep 2005 Dec 9;54(RR-14):1-16).
34. Mark A, Granström M. Impact of pertussis on the afflicted child and family. Ped Infect Dis J 1992;11:554—7).
35. Postels-Moltani S, SchmittHJ, Wirsing von Konig CH, et al. Symptoms and complications of pertussis in adults. Infection 1995;23:139—42).
36. Skoff TH, Cohn AC, Clark TA, et al. Early Impact of the US Tdap Vaccination Program on Pertussis Trends. Arch Pediatr Adolesc Med. 2012;166(4):344-349;
37. Halasa NB, Barr FE, Johnson JE, Edwards KM. Fatal pulmonary hypertension associated with pertussis in infants: does extracorporeal membrane oxygenation have a role? Pediatrics 2003;
112:1274-8;
38. Paddock CD, Sanden GN, Cherry JD, et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 2008 Aug 1;47(3):328-38).
39. T.C .Cumhurbaşkanlığı Mevzuat Bilgi Sistemi Bulaşıcı Hastalıklar Sürveyans ve Kontrol Esasları Yönetmeliği Eki: Ek–I (Değişik:Rg-4/5/2019-30764) Bildirime Esas Bulaşıcı Hastalıklar Lis-
tesi, Boğmaca S9. Resmî Gazete Tarihi: 30.05.2007 Resmî Gazete Sayısı: 26537.
40. Nar Ötgün S, Türkekul Şen E, Şaylı O, Esen B, Durmaz R. Boğmaca Hastalığının Laboratuvar Tanısında Kültür ve Polimeraz Zincir Reaksiyonunun Değerlendirilmesi. Kocatepe Tıp Dergisi
2020; 21: 6-11
41. Selin Nar Ötgün, Bülant Acar, Cüret Alev, Berrin Esen. Pertussis suşlarının antibiyotik duyarlılık araştırması. P136. 35. Türk Mikrobiyoloji Kongresi, 3-7 Kasım 2012, Kuşadası, Aydın.
42. Emek Türkekul Şen, Berrin Esen, Ayşegül Gözalan, Ayfer Özışık, Fatma İnci Arıkan, Selin Nar Ötgün, Esra Karakoç, Ayça Yeniaras, Meral Turan, Ali Kudret Adiloğlu. 0-1 yaş çocuklarda
kültür in-house Polimeraz zincir reaksiyonu (PZR) ve lightcycler PZR yöntemleriyle boğmaca hastalığına neden olan türlerin saptanması. SS43, 3. Ulusal Klnik Mikrobiyoloji Kongresi 18-22
Kasım 2015, Antalya.
43. Güldemir D, Akbaş E, Nar Ötgün S, Tekin A, Esen B. Boğmacanın Moleküler Tanısı İçin Laboratuvar Yapımı Bir PCR Yönteminin Geliştirilmesi ve Optimizasyonu [Development and opti-
mization of an in-house PCR method for molecular diagnosis of pertussis]. Mikrobiyol Bul. 2011;45(4):632-645.
44. Guiso N, Berbers G, Fry NK, et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis.
2011;30(3):307-312. doi:10.1007/s10096-010-1104-y
45. Stefanelli P, Mostrantonio P, Hausman SZ, Giuliano M, Burns DL. Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs. J Clin Microbiol
1997;35:1550—5
46. Yih WK, Silva EA, Ida J, Harrington N, Lett SM, George H. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis 1999;5:441-
3
47. Center and Disease Prevention (CDC).https://www.cdc.gov/pertussis/clinical/treatment.html (Erişim Tarihi: 24 Kasım 2023)
48. American Academy of Pediatrics. [Pertussis (Whooping Cough)] In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2018 Report of the Committee on Infectious Diseases.
31st ed. Itasca, IL: American Academy of Pediatrics; 2018: [620-634] 49. Friedman DS, Curtis RC, Schauer SL, et al. Surveillance for transmission and antibiotic adverse events among neonates and adults exposed to a healthcare worker with pertussis. Infect Control
Hosp Epidemiol 2004;25:967—73
50. Honein MA, Paulozzi LJ, Himelright IM, et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet 1999;354:2101-5.
51. Center and Disease Prevention (CDC). https://www.cdc.gov/pertussis/pep.html (Erişim Tarihi: 24 Kasım 2023);
52. Center and Disease Prevention (CDC). Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR. 2005;54(RR14):1-
16.;
53. von König CH. Use of antibiotics in the prevention and treatment of pertussis. Pediatr Infect Dis J. 2005;24(5 Suppl):S66–8;
54. Hardy DJ, Hensey DM, Beyer JM Voktko c, McDonald EJ, Fennandes PB. Comparative in vitro activities of new 14-, 15, and 16-membered macrolides. Antimicrob Agents Chemother
1988;32:1710—9.
55. Guiso N, Meade BD, Wirsing-von-König CH. Per- tussis vaccines: The first hundred years. Vaccine. 2020;38(5):1271–6
56. Pertussis vaccines: WHO position paper, August 2015—recommendations. Vaccine. 2016;34(12): 1423–5.
57. Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P, et al. Pertussis prevention: reasons for resurgence, and differences in the current acellular pertussis vaccines. Front Immunol. 2019;
10:01344.
58. Klein NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics, 2013;131:e1716-22
59. Edwards KM, et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 1995; 96 : 548–557).
60. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet 2006; 367: 1926–1936
61. Mooi FR. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerging Infectious Diseases 2009; 15: 1206–1213.
62. Olin P, Gustafsson L, Barreto L, Hessel L, Mast TC, Rie AV, Bogaerts H, Storsaeter J. Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine
2003; 21:2015–2021
63. Selin Nar Ötgün, Zekiye Bakkaloğlu, Bülent Acar, Özlem Ünaldı, Rıza Durmaz. Bordetella pertussis suşlarında fimbriyal serotiplerin ve pertaktin-pertussis toksin S1 sekans tiplerinin araştır-
lması. S.1.8. 35. Türk Mikrobiyoloji Kongresi, 3-7 Kasım 2012, Kuşadası, Aydın. ECCMID 2013, Berlin, Almanya P1969.
64. Nar Otgun S, Durmaz R, Karagoz A, Esen B, Ertek M. Pulsed-field gel electrophoresis characterization of Bordetella pertussis clinical isolates circulating in Turkey in 2001-2009. Eur J Clin
Microbiol Infect Dis. 2011;30(10):1229-1236. doi:10.1007/s10096-011-1217-y
65. Center and Disease Prevention (CDC). https://www.cdc.gov/vaccines/vpd/dtap-tdap-td/hcp/recommendations.html (Erişim tarihi: 28 Kasım 2023)
66. Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Com-
mittee on Immunization Practices — United States, 2019. MMWR, January 24, 2020, Vol 69(3);77-83;
67. Immunization of Health-Care Personnel. recom- mendations of the Advisory Committee on Immu- nization Practices (ACIP). MMWR Recomm Rep. 2011;60(Rr-7):1–45
68. Nilay 42. Mesleğe Bağlı Riskler Nedeniyle Aşılama. https://asi.saglik.gov.tr/asi/asi-kimlere-yapilir/liste/32-mesle%C4%9Fe-ba%C4%9Fl%C4%B1-riskler-nedeniyle-a%C5%9F%C4%B1lama.
html
69. Rowe SL, Tay EL, Franklin LJ, et al. Effectiveness of parental cocooning as a vaccination strategy to prevent pertussis infection in infants: A case-control study. Vaccine. 2018;36(15):2012-2019.
doi:10.1016/j.vaccine.2018.02.094.
70. Kurugol Z. Pertussis epidemiology in Turkey: are booster doses necessary?/Turkiye’de bogmaca epi- demiyolojisi pekistirme asi dozlari gerekli mi? J Pediatr Infect. 2009;14
71. Pehlivan T, Dinleyici EC, Kara A, Kurugol Z, Tezer H, Aksakal NB, Biri A, Azap A. The Present and Future Aspects of Life-Long Pertussis Prevention: Narrative Review with Regional Pers-
pectives for Türkiye. Infect Dis Ther 2023;12:2495–2512)
72. TC Sağlık Bakanlığı Aşı Takvimi (https://asi.saglik.gov.tr/asi/asi-takvimi).
73. Clark TA, Messonnier NE, Hadler SC. Pertussis control : time for something new ? Trends in Microbiology 2012 ; 20 : 211–213
74. Cherry JD. The present and future control of pertussis. Clinical Infectious Diseases 2010 ; 51 : 663–667
75. Sheridan SL, et al. Number and order of whole cell pertussis vaccines in infancy and disease protection. Journal of the American Medical Association 2012 ; 308 : 454–456.
76. Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics 2011; 3: 183–188).
77. Versteegh FGA, Edwards KM. How to fight whooping cough? Archives of Pediatrics and Adolescent Medicine 2012 ; 166 : 389–391.
78. Jefferson T, Rudin M, DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine 2003 ; 21 : 2003–2014.
79. Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatric Infectious Disease Journal 2005 ; 24 : S10–S18.
80. Anderson RM, May RM, McLean A. Possible demographic consequences of AIDS in developing countries. Nature 1988 ; 332 : 228–234
81. Jackson DW, Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol. Infect. (2014), 142, 672–684)